Brief Information of the Cell Line and Protein
Cell Line ID: CL000006 , HEK293
Synonyms
Hek293
HEK-293
HEK/293
HEK 293
HEK;293
293
293 HEK
293 Ad5
Graham 293
Graham-293
Human Embryonic Kidney 293
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0045
Protein ID: PT01526 , Delta-type opioid receptor
Gene Name OPRD1
Organism Rattus norvegicus, Rat
Protein Classification Membrane receptor
Uniprot ID P33533
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000006  Protein ID: PT01526
 
Compound ID Compound Name Compound Formula
CP0548660
(S)-4-((S)-2-{(R)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-4-{(S)-1-[(S)-1-(carboxymethyl-carbamoyl)-2-methyl-propylcarbamoyl]-2-methyl-propylcarbamoyl}-butyric acid
   Show/Hide
C38H53N7O11
 1
1
EC50 = 0.1 nM
   TI
   LI
   LO
   TS
CP0545965
2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]acetic acid
   Show/Hide
C28H39N7O6
 1
1
EC50 = 1.13 nM
   TI
   LI
   LO
   TS
CP0552003
2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]acetic acid
   Show/Hide
C25H32N4O6
 1
1
EC50 = 2.4 nM
   TI
   LI
   LO
   TS
CP0548659
(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]propanoyl]-methylamino]-N-(2-amino-2-oxoethyl)-3-(2-ethenylphenyl)propanamide
   Show/Hide
C28H37N5O5
 1
1
EC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0413476
(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]propanoyl]amino]-N-(2-amino-2-oxoethyl)-3-(2-phenylphenyl)propanamide
   Show/Hide
C31H37N5O5
 1
1
EC50 = 4.9 nM
   TI
   LI
   LO
   TS
CP0386949
(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]propanoyl]amino]-N-(2-amino-2-oxoethyl)-3-(2-ethenylphenyl)propanamide
   Show/Hide
C27H35N5O5
 1
1
EC50 = 5.8 nM
   TI
   LI
   LO
   TS
CP0393121
(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(2-ethenylphenyl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)pentanamide
   Show/Hide
C30H42N8O5
 1
1
EC50 = 7 nM
   TI
   LI
   LO
   TS
CP0417239
(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-[2-(2-methylprop-1-enyl)phenyl]-1-oxopropan-2-yl]-5-(diaminomethylideneamino)pentanamide
   Show/Hide
C32H46N8O5
 1
1
EC50 = 19.4 nM
   TI
   LI
   LO
   TS
CP0545964
(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-3-[4-(trifluoromethyl)phenyl]propan-2-yl]-5-(diaminomethylideneamino)pentanamide
   Show/Hide
C29H39F3N8O5
 1
1
EC50 = 26.8 nM
   TI
   LI
   LO
   TS
CP0043301
(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-N-methylacetamido}-N-(2-hydroxyethyl)-3-phenylpropanamide
   Show/Hide
C26H35N5O6
 1
1
EC50 = 49 nM
   TI
   LI
   LO
   TS
CP0386948
(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-3-(2-thiophen-3-ylphenyl)propan-2-yl]-5-(diaminomethylideneamino)pentanamide
   Show/Hide
C32H42N8O5S
 1
1
EC50 = 49 nM
   TI
   LI
   LO
   TS
CP0475884
(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]propanoyl]amino]-N-(2-amino-2-oxoethyl)-3-(2-thiophen-3-ylphenyl)propanamide
   Show/Hide
C29H35N5O5S
 1
1
EC50 = 56 nM
   TI
   LI
   LO
   TS
CP0182209
5'-[N-(N'-Cyano)guanidinyl]-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C28H28N6O3
 1
1
Ki = 9.46 nM
   TI
   LI
   LO
   TS
CP0377768
2-[2-[(1S,2S,13R,21R)-22-(cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-7-yl]ethyl]guanidine
   Show/Hide
C29H33N5O3
 1
1
Ki = 10.7 nM
   TI
   LI
   LO
   TS
CP0505602
5'-(Dimethylamino)methyl-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C29H33N3O3
 1
1
Ki = 15.7 nM
   TI
   LI
   LO
   TS
CP0381067
2-[[(1S,2S,13R,21R)-22-(cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-7-yl]methyl]guanidine
   Show/Hide
C28H31N5O3
 1
1
Ki = 30.8 nM
   TI
   LI
   LO
   TS
CP0430310
5'-Amidinomethyl-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C28H30N4O3
 1
1
Ki = 33 nM
   TI
   LI
   LO
   TS
CP0041449
C18130
   Show/Hide
C40H43N3O6
 1
1
Ki = 41.5 nM
   TI
   LI
   LO
   TS
CP0054764
2-[(1S,2S,13R,21R)-22-(cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-7-yl]guanidine
   Show/Hide
C27H29N5O3
 1
1
Ki = 46.2 nM
   TI
   LI
   LO
   TS
CP0848535
5'-(Trimethylammonium)methyl-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan Iodide
   Show/Hide
C30H36IN3O3
 1
1
Ki = 78.4 nM
   TI
   LI
   LO
   TS
CP0409091
5'-N-Biguanidino-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C28H31N7O3
 1
1
Ki = 108 nM
   TI
   LI
   LO
   TS
CP0405336
5'-Amidino-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C27H28N4O3
 1
1
Ki = 112 nM
   TI
   LI
   LO
   TS
CP0402523
6,7-Dihydro-4,5alpha-epoxy-5'-guanidinyl-17-methyl-3,14-dihydroxyindolo[2',3':6,7]morphinan
   Show/Hide
C24H25N5O3
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS